PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Capital expenditures, 2025
- $1.6M
- YoY, 2025
- +17.3%
- 5-year CAGR
- +27.5%
- 10-year CAGR
- +14.8%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $1.6M | +17.3% |
| 2024 | $1.4M | +122.5% |
| 2023 | $609K | −23.4% |
| 2022 | $795K | −27.8% |
| 2021 | $1.1M | +133.8% |
| 2020 | $471K | −51.3% |
| 2019 | $967K | +99.0% |
| 2018 | $486K | −27.0% |
| 2017 | $666K | +91.9% |
| 2016 | $347K | −13.0% |
| 2015 | $399K | +33.4% |
| 2014 | $299K | — |